The discussions reflect a positive reception, with comments highlighting the importance of the research, such as the mention that CYP2B6 polymorphisms influence drug exposure and the potential for personalized dosing. Phrases like 'Opportunities to study' and references to 'meta-analysis of 10 studies' indicate a serious, analytical tone that underscores the significance and relevance of these findings in clinical contexts.
AgreementModerate agreement
Most posts acknowledge the significance of the research findings, particularly emphasizing the genetic influence on drug metabolism.
InterestHigh interest
Discussions demonstrate high interest, with mentions of precision medicine and genetic testing as promising avenues.
EngagementModerate engagement
Posts show moderate engagement by referencing details like the number of studies and potential clinical implications.
ImpactModerate impact
The studies are seen as potentially impactful, especially concerning personalized treatment strategies and the future of pharmacogenetics.
Abstract in brief
This study investigates how different genetic variations (polymorphisms) in the CYP2B6 enzyme affect the levels of bupropion and its active metabolite, hydroxybupropion, in the blood, through a systematic review and meta-analysis.
The research found that individuals carrying the CYP2B6*6 allele, especially poor and intermediate metabolizers, have significantly lower exposure to bupropion and hydroxybupropion compared to those with normal metabolism, indicating genetic differences impact drug metabolism.
The findings highlight the importance of CYP2B6 genetic testing to potentially optimize bupropion dosing and improve treatment effectiveness, as genetic variations influence how the drug is processed in the body.]
Meta-analysis of 10 studies in healthy people (n=413) found CYP2B6 genotype-inferred poor & intermediate metabolizers had sig lower exposure to bupropion + hydroxybupropion (active moiety) relative to normal metabolizers. @pgrnhub @cpicpgx @PharmacoJournal https://t.co/OCCFV7wcG0
Nov 13, 2021 · 20 likes · 4 shares · 852 followersView post →
P
Pharmacotherapy
@PharmacoJournal · X
The findings of this study suggest opportunities to further study precision dosing strategies for bupropion therapy based on CYP2B6 genotype. https://t.co/RzS5wM4Xrd @pkpdpg https://t.co/NNyqVATZfJ
Nov 17, 2021 · 3 likes · 11,870 followersView post →
GL
Garbiñe Lizeaga
@GarbineLizeaga · X
Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta‐analysis https://t.co/dgskJ6tzuR
Nov 16, 2021 · 1 like · 1,223 followersView post →
S
SystematicReviewBot
@EvidenceRobot · X
RT @BousmanChad: Meta-analysis of 10 studies in healthy people (n=413) found CYP2B6 genotype-inferred poor & intermediate metabolizers had…
Nov 13, 2021 · 4 shares · 6,686 followersView post →
RD
Ruslan Dorfman
@RuslanDorfman · X
RT @BousmanChad: Meta-analysis of 10 studies in healthy people (n=413) found CYP2B6 genotype-inferred poor & intermediate metabolizers had…
Nov 15, 2021 · 4 shares · 1,009 followersView post →
PP
PSY-PGx
@PSY_PGx · X
RT @BousmanChad: Meta-analysis of 10 studies in healthy people (n=413) found CYP2B6 genotype-inferred poor & intermediate metabolizers had…
Nov 14, 2021 · 4 shares · 488 followersView post →
Learn why your genetics can make all the difference in how well this antidepressant works for you or your patients. This study shows genetic variations, especially CYP2B6*6 allele, influence drug levels, emphasizing the…
This video explores how genetic variations in the CYP2B6 enzyme impact bupropion and hydroxybupropion levels, affecting treatment outcomes. Understand the importance of pharmacogenetics for personalized medication…
The findings of this study suggest opportunities to further study precision dosing strategies for bupropion therapy based on CYP2B6 genotype. https://t.co/RzS5wM4Xrd @pkpdpg https://t.co/NNyqVATZfJ
Nov 17, 2021 · 3 likes · 11,870 followersView post →
GL
Garbiñe Lizeaga
@GarbineLizeaga · X
Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta‐analysis https://t.co/dgskJ6tzuR
Nov 16, 2021 · 1 like · 1,223 followersView post →
RD
Ruslan Dorfman
@RuslanDorfman · X
RT @BousmanChad: Meta-analysis of 10 studies in healthy people (n=413) found CYP2B6 genotype-inferred poor & intermediate metabolizers had…
Nov 15, 2021 · 4 shares · 1,009 followersView post →
PP
PSY-PGx
@PSY_PGx · X
RT @BousmanChad: Meta-analysis of 10 studies in healthy people (n=413) found CYP2B6 genotype-inferred poor & intermediate metabolizers had…
Nov 14, 2021 · 4 shares · 488 followersView post →
S
SystematicReviewBot
@EvidenceRobot · X
RT @BousmanChad: Meta-analysis of 10 studies in healthy people (n=413) found CYP2B6 genotype-inferred poor & intermediate metabolizers had…
Nov 13, 2021 · 4 shares · 6,686 followersView post →
FB
Francois Bernier
@Genedoc35 · X
RT @BousmanChad: Meta-analysis of 10 studies in healthy people (n=413) found CYP2B6 genotype-inferred poor & intermediate metabolizers had…
Nov 13, 2021 · 4 shares · 345 followersView post →
CB
Chad Bousman
@BousmanChad · X
Meta-analysis of 10 studies in healthy people (n=413) found CYP2B6 genotype-inferred poor & intermediate metabolizers had sig lower exposure to bupropion + hydroxybupropion (active moiety) relative to normal metabolizers. @pgrnhub @cpicpgx @PharmacoJournal https://t.co/OCCFV7wcG0
Nov 13, 2021 · 20 likes · 4 shares · 852 followersView post →
T
What Does Cotton Pad and Orange Juice Do | TikTok
TikTok
2644 Likes, 55 Comments. TikTok video from blaine (@_blainnee): “. 23.3K1w ... 10.1002/biof.1363 https://www.cambridge.org/core/journals/british-journal ...